SAN DIEGO, April 02, 2026 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that Trey Pope, CRPC®, ABFP®, has joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. Pope reported serving approximately $160 million in advisory, brokerage and retirement plan assets* and joins LPL from Edward Jones. Based outside of Huntsville, Alabama, Pope brings more than a decade of industry experience and serves a diverse client base that includes engineers, medical professionals, government employees and retirees, many of whom are in their peak earning years or planning for retirement. His practice is built around long-term relationships and a planning-first approach designed to help clients align their financial strategies with their personal values, long-term goals and legacy objectives. “Every relationship...

One wedding. Every perspective. Shared in real time. NEW BRUNSWICK, N.J., April 02, 2026 (GLOBE NEWSWIRE) — Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”), a privacy-first social media and technology innovator, today announced a new initiative to bring its Picture Party platform to 10,000 weddings, giving couples a free, instant private social network designed specifically for their event. Weddings are among the most photographed moments in people’s lives, yet the majority of guest-captured photos never make it beyond individual camera rolls or fragmented group chats. Picture Party changes that by creating a single, real-time space where every photo, video and message from the event lives, captured from every angle, by every guest. Through Picture Party, couples can launch a dedicated, private social network for their wedding,...

DALLAS, April 02, 2026 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (NYSE: CSW) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.30 per share, representing an increase of $0.03 per share, or approximately 11%, from the prior quarter. The dividend is payable on May 8, 2026, to shareholders of record as of the close of business on April 24, 2026. “We are pleased to announce the seventh increase in our quarterly dividend, reflecting our positive outlook for fiscal year 2027 as demonstrated by our strong balance sheet, cash flow generation and profitability. Since October 2017, CSW has returned over $368 million in cash to our shareholders through dividends and share repurchases, while delivering impressive organic growth and value-accretive acquisitions,” said Joseph B. Armes, CSW Industrials...

If approved, UX111 will be the first approved therapy for the treatment of Sanfilippo syndrome Type A, a rare disease affecting young children that leads to progressive, irreversible neurodegeneration and early death PDUFA action date set for September 19, 2026 NOVATO, Calif., April 02, 2026 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the U.S. Food and Drug Administration (FDA or the Agency) has accepted for review the resubmitted Biologics License Application (BLA) seeking accelerated approval for UX111 (rebisufligene etisparvovec) AAV9 gene therapy as a treatment for patients with Sanfilippo syndrome Type A (MPS IIIA). The FDA set a Prescription Drug User Fee Act (PDUFA) action date of September 19, 2026. “The FDA’s acceptance of the BLA for UX111 brings us closer to the possibility of a first-ever...

CLEVELAND, April 02, 2026 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of NewYork-Presbyterian/Columbia University Irving Medical Center in New York, NY as the newest Qualified Treatment Center (QTC) for the administration of ZEVASKYN (prademagene zamikeracel) gene-modified cellular sheets. “Activation of NewYork-Presbyterian/Columbia University Irving Medical Center as our fifth QTC significantly expands patient access to ZEVASKYN in the New York metropolitan area and across the Northeast,” said Dr. Madhav Vasanthavada, Chief Commercial Officer of Abeona. “Partnering with an institution recognized globally for its leadership in genetic medicines and long history in managing blistering skin disorders means that our patients will be supported by world-class clinical expertise throughout their...

Fiserv Small Business Index rises to 144; year-over-year sales grew +1.3% MILWAUKEE, April 02, 2026 (GLOBE NEWSWIRE) — Fiserv, Inc. (NASDAQ: FISV), a leading global provider of payments and financial services technology, has published the Fiserv Small Business Index for March 2026, indicating that U.S. small business sales continued to grow steadily in March, despite consumers being more selective in their spending. Higher average ticket sizes helped offset slower transaction volumes as small businesses closed out Q1 on solid footing. The seasonally adjusted Index rose to 144. Year-over-year sales grew (+1.3%) despite transactions (foot traffic) slowing (-1.3%). Month-over-month sales (+0.7%) and foot traffic (+0.5%) both grew slightly compared to February. With total transactions easing, sales growth was buoyed by higher average...

Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances second phase of clinical program for 510(k) submission with method comparison, usability, and interference testing NEW YORK, April 02, 2026 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of its initial clinical Cut-off Study supporting the Company’s FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for detection of the opiate codeine. The clinical Cut-off Study evaluated codeine detection cut-off levels in 40 adults, with full data analysis completed as planned by...

TORONTO, April 02, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced that the United States District Court for the Southern District of New York has largely ruled against defendants CIBC World Markets (“CIBC”) and RBC Dominion Securities (“RBC”) joint motion to dismiss Quantum Biopharma’s lawsuit alleging illegal market manipulation. The Quantum Biopharma lawsuit alleges that between January 1, 2020, and August 15, 2024, the Defendants and/or their customers used “spoofing” techniques to manipulate the share price of Quantum BioPharma shares. The Company alleges that these market manipulation schemes violated Section 10(b) and Rule 10b-5(a)...